Genomind Expands Mental Health Genetic Testing Services with New Genomind Professional PGx Express
Genomind launches Genomind Professional PGx Express™, a new, more focused report and set of services to enhance its mental health genetic testing.
Genomind Launches the Most Comprehensive Genetics-Based Mental Health Test Available, Genomind Professional PGx, to Help Clinicians Optimize Mental Health Medication Decisions
Genomind Launches the Most Comprehensive Genetics-Based Mental Health Test Available, Genomind Professional PGx, to Help Clinicians Optimize Mental Health Medication Decisions.
Genomind Inc. Recruits Group of World-Renowned Experts in Psychiatry and Neurology to Advance its Commitment to Mental Health Innovation
Genomind Inc. Recruits Group of World-Renowned Experts in Psychiatry and Neurology to Advance its Commitment to Mental Health Innovation.
Genomind Strengthens its Leadership Team with Hiring of Experienced CEO, President and Internal Promotions
Shawn Patrick O’Brien and Kip Olmstead Bring Decades of Global Biotech Leadership and Marketing Experience to the King of Prussia-Based Company Disrupting Genetic Testing.
Genomind to Host Facebook Live Discussion During Mental Health Awareness Week
To kick off Mental Health Awareness Week, Genomind® patients will go live on Facebook to share about their experiences with Genomind’s Genecept Assay®.
Mindful DNA® Professional, Genetic Testing for Personalized Wellness, Forms Wellness Advisory Board of Medical and Research Leaders
Mindful DNA® Professional, Genetic Testing for Personalized Wellness, Forms Wellness Advisory Board of Medical and Research Leaders.
Standard Process Partners With Genomind® To Offer Mindful DNA – A Breakthrough In Personalized Wellness
Standard Process Partners With Genomind® To Offer Mindful DNA – A Breakthrough In Personalized Wellness.
Personalized Medicine Advances With First-of-its-Kind Partnership between Genomind® and Albertsons Sav-On, Jewel-Osco and Acme Sav-On
Personalized Medicine Advances With First-of-its-Kind Partnership between Genomind® and Albertsons Sav-On, Jewel-Osco and Acme Sav-On.
New Research Suggests Genetic Testing May Help Improve Costs Associated with Mental Health Treatment
New research suggests genetic testing may help improve costs associated with mental health treatment.
A Breakthrough in Personalized Wellness: Mindful DNA® Professional Genetic Testing
Genomind launches Mindful DNA to healthcare providers looking for genetic guidance on lifestyle, diet, and/or nutritional supplement decisions.
Genomind Patient Gateway Launches as an Easy Way to Access Patient Education and Track Health
Genomind® Patient Gateway Launches as an Easy Way to Access Patient Education and Track Health.
Trio of Awards Cap Ground-Breaking Year for Genomind and Its Unique Platform
Trio of Awards Cap Ground-Breaking Year for Genomind and Its Unique Platform.
More Americans Than Ever Embrace Genetic Testing To Aid In Mental Health Treatment, According To Annual Genomind® Mental Health Poll™
More Americans Than Ever Embrace Genetic Testing To Aid In Mental Health Treatment, According To Annual Genomind® Mental Health Poll™.
Clinicians Gain Powerful New Tool When Treating Patients For Mental Illness: G-DIG, Exclusively From Genomind, Enhances Personalized Medicine
Clinicians Gain Powerful New Tool When Treating Patients For Mental Illness: G-DIG, Exclusively From Genomind, Enhances Personalized Medicine.
Multiple Honors and Recognition for Genomind as a Record of Success Continues
Genomind continues to collect a notable set of awards as it builds on its strategic plan.
Penguin Random House Publishes Widely Praised Book Authored by Co-Founder of Genomind®
Penguin Random House Publishes Widely Praised Book Authored by Co-Founder of Genomind®.
Genomind’s Industry Accolades Expand, Bolstered by a Strong Scientific Advisory Board
Genomind’s Industry Accolades Expand, Bolstered by a Strong Scientific Advisory Board.
Mental Health Awareness Month: Genomind® Recognizes Psychiatrist Who Made a Difference During Pulse Nightclub Tragedy
With May being Mental Health Awareness Month, Genomind is recognizing a psychiatrist whose dedication to helping patients went above and beyond.
Genomind® Reaches Milestone, Expands Headquarters to Meet Demand
Genomind announced a headquarters expansion and its Genecept Assay® has been used to aid clinicians in treating a total of over 100,000 patients.
Genomind® Receives Emerging Company of the Year Award from Life Sciences Pennsylvania
Representing the entire life sciences industry in the state, Life Sciences Pennsylvania has named Genomind its Emerging Company of the Year.
Genomind® Completes $11 Million Financing to Fund Business Expansion
Genomind has completed an $11 million financing with its existing shareholders and Silicon Valley Bank (SVB) to further fuel Genomind’s expansion.
Genomind® Looks Forward to Growth in New Year as it Reflects on 2016 Accomplishments
Genomind® Looks Forward to Growth in New Year as it Reflects on 2016 Accomplishments.
Clinicians Treating Patients With Depression and Substance Abuse May Find Answers With Genetic Testing
An educational webinar explores how genetic testing can help clinicians with patients dealing with those who suffer from MDD and substance use disorder.
Recognition Grows for Genomind as a Leader in Genetic Testing for Mental Health Treatment
Genomind, a personalized medicine company bringing innovation to mental health care through genetic testing, continues to receive awards and recognition.
Americans Embrace Genetic Testing for Chronic Diseases, Yet Mental Illness Still Lags Behind Others, Survey Finds
According to the Genomind Mental Health Poll, Americans have divergent views about genetic testing for chronic diseases versus testing for mental illness.
Clinicians Prepare to Learn How Genomind’s Genecept Assay® Can Help in ADHD Treatment
Genomind will present an educational webinar for clinicians interested in learning how the test can help guide personalized ADHD treatment for patients.
Genomind Named One of the Best Places to Work in Healthcare
Genomind was recently named one of the best places to work in healthcare by Modern Healthcare Magazine and Best Companies Group.
Genetic Testing for ADHD Patients From Genomind Can Help Them Get Better
Summer is ideal to diagnose and treat ADHD. Clinicians who use Genomind’s Genecept Assay® say testing young patients when they aren’t in school makes sense.
Rep. Brendan Boyle Tour of Genomind Lab In King of Prussia to Showcase Personalized Medicine for Mental Health
Genomind lab will highlight the importance of the biotech industry to Pennsylvania when Representative Brendan Boyle tours its lab.
‘Dr. Phil’ Show to Feature Genomind’s Genecept Assay in Upcoming Program Aimed at Helping a Patient Get Better
Genomind will soon be featured in a nationally broadcast episode of “Dr. Phil”, highlighted as part of a program focused on helping a family in crisis.